ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Reversal learning paradigm reveals deficits in cognitive flexibility in the Fmr1 knockout male mouse

[version 1; peer review: 1 approved, 2 approved with reservations]
PUBLISHED 07 Jun 2018
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background: Loss of FMR1 is associated with Fragile X syndrome, amongst the most prevalent inherited intellectual disability. Despite extensive research in this area, previous studies have failed to detect consistent evidence of cognitive impairments in the Morris water maze (MWM) task in the Fmr1 knockout (KO) mouse. However, few studies have examined cognitive flexibility in a reversal form of the MWM task, which may illuminate subtle learning deficits.
Methods: Adult male Fmr1 wildtype (WT) and KO mice were bred and tested in the MWM reversal paradigm. The testing paradigm consisted of two blocks per day, with 4 trials per block to locate a hidden platform. After the last trials on the fourth day of testing, the animals were given a probe trial with the platform removed. The following week, the location of the platform was switched to the opposite quadrant and the animals received 2 more days of testing, with 4 blocks in total.
Results: As expected, Fmr1 KO mice did not display a learning deficit during the acquisition phase, Fgenotype (1, 24) = 0.034, p = 0.854, and performed similarly on the probe trial, Fgenotype (1, 23) = 0.024, p = 0.877. However, during the reversal phase of learning, Fmr1 KO mice showed deficits in their ability to learn the new location of the platform, Fgenotype (1, 23) = 3.93, p = 0.059. Further independent samples t-testing revealed that KO animals displayed significantly higher latency to reach the hidden platform during the third trial, t(23) = -2.96, p < 0.01.
Conclusions: While previous studies have not demonstrated deficits in spatial memory in the Fmr1 KO model, it is possible that the acquisition phase of the task is less sensitive to deficits in learning. Future studies using this model to evaluate therapeutic interventions should consider utilizing the MWM reversal paradigm.

Keywords

Cognitive flexibility, Autism, Morris water maze, Prefrontal cortex, FMRP

Introduction

Fragile X syndrome (FXS) is a neurodevelopmental disorder, caused by a trinucleotide expansion mutation in the FMR1 gene, and is also one of the most prevalent inherited forms of intellectual disability1. FXS is often modeled using the Fmr1 knockout (KO) mouse, which can be characterized by several behavioral phenotypes, including alterations in sociability and deficits in fear memory24. Aside from deficits in spatial and non-spatial learning, one understudied facet of intellectual disability is the ability to incorporate new information into existing learning, termed cognitive flexibility. Cognitive flexibility can be studied in rodents using a variant of the Morris water maze (MWM) paradigm5,6. In the MWM reversal paradigm, the location of the hidden platform is moved, and the latency to adjust to the new location is measured. As expected, several reports find evidence of impairments in reversal learning in the Fmr1 KO mouse across multiple strains, the C57BL/6J backcrossed strain7,8 and the albino C57BL/6J background2. However, other studies have been unable to replicate these findings, and further investigation points to the possibility of background strain differences9. Previous reports have not detected any impairments in reversal learning in the FVB.129 strain10. However, it may be that this paradigm is perhaps even more sensitive to methodological differences. The current study adds to this literature by using the FVB.129 strain in a previously utilized paradigm.

Methods

Animals

Male Fmr1+/+ and female Fmr1+/- FVB.129P2-Pde6b+Tyrc-ch Fmr1tm1Cgr/J (Stock No: 004624, The Jackson Laboratory, Bar Harbor, ME, USA) mice were used as breeders (9 total breeding pairs) to produce the following groups: male WT and male KO pups. Breeding pairs were of the following groupings: WT Female/WT Male (n = 2), KO Female/KO Male (n = 5), WT Female/KO Male (n = 2). Genotype was determined from toe clippings taken prior to age postnatal day (PD) 12 (Mouse Genotype, Escondido, CA, USA). The final sample sizes were as follows: nmale WT = 10, nmale KO = 16. Target samples sizes (n = 10) were calculated a priori using a power calculation in G*Power 3.1 with the following parameters: f = 0.50 (large effect), α = 0.05, power (1 – β) = 0.80, for the F family of tests with two groups and 8 repeated measures (trials). All pups were housed in individual cages (Allentown Caging PC7115HT, Allentown, PA, USA), filled with sani-chip bedding (7090 Teklad, Envigo, Somerset, NJ, USA). Prior to weaning on PD21, pups were housed with parents (1 male and 2 females) and littermates (up to 12 pups). Following weaning, subjects were housed with mixed genotype littermates, no more than 5 to a cage. The light cycle was kept at 12 hr. light, and the colony room was kept at an ambient temperature of 22° C. Animals had ad libitum access to food and water. All procedures performed were in accordance with Baylor University Institutional Animal Care and Use Committee (Animal Assurance Number A3948-01), as well as the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. All efforts were made to ameliorate any stress and harm to the animals, specifically by habituating animals to the testing apparatus and room prior to trial recordings.

Morris water maze

All behavioral testing was conducted during the light cycle, specifically between 8 am and 5 pm. The methods for the current study were adapted as closely as possible from earlier studies of this behavior in the Fmr1 KO mouse (represented in Figure 1)9. Briefly, a 1.3 m diameter white pool was filled with water and made opaque through the addition of non-toxic white paint (Item LT3010, S&S Worldwide, Connecticut). The hidden platform measured 14.5 cm × 14.5 cm and was submerged approximately 2 cm below the water level. The testing paradigm consisted of two blocks per day for 4 days, with 4 trials in each block, for each mouse to test the ability to locate a hidden platform. The mice were habituated to the testing room in their holding cages for 30 minutes prior to the onset of testing. The amount of time spent in each quadrant for each trial was recorded with a ceiling-mounted video camera (Ganz YCH-02, Cary, NC, USA), and analyzed using automated tracking software (Ethovision XT 6, Noldus, Wageningen, Netherlands). After the last trial on the fourth day of testing was completed, the animals were given a probe trial. The probe trial involved removing the platform and allowing the subjects to explore the maze for 60 seconds. During the probe trial, the number of times the animal crossed the location of the hidden platform and the duration of time in each quadrant was calculated. Testing resumed on day 8 after a 3-day rest period. On day 8, the platform was placed in the opposite quadrant from the previous location that housed the hidden platform. Testing progressed as with the initial acquisition phase, with 2 blocks per day for 2 days. On the final day of testing, a visible platform was used to evaluate visual performance as well as swim speed. The visible platform was a two-tiered platform similar to the initial platform, with a second higher tier platform that extended 9.5 cm above the lower platform, allowing the animal to see the platform. The differences in methodology from the cited source were as follows: only four days of acquisition were conducted and the testing paradigm was lengthened to account for a consolidation period between the learning and reversal trials (See Figure 1 for a description of the testing paradigm). One KO animal was excluded from analysis due to a seizure during this task.

fdb96939-aa16-44c5-b9e7-acaab153248e_figure1.gif

Figure 1. Overview of the testing paradigm.

A. An overview of the set-up of the testing arena. B. An overview of the progression of testing days.

Statistical analysis

Statistical analysis was performed in the form of a one-way analysis of variance (ANOVA) with one between-subjects factor (Genotype [wildtype, knockout]) and one within-subjects factor (Trial). All data were analyzed using GraphPad Prism Software 7.0 (San Diego, CA, USA) or IBM SPSS Statistics 23 (Aramonk, NY, USA).

Results

Fmr1 KO mice show no impairment in acquisition of spatial memory

To investigate the effect of genotype on hippocampal spatial memory, animals were tested in the MWM paradigm (Dataset 1). During the 8 blocks of learning trials (Figure 2A), there was a significant within-subjects effect of trial for latency to reach the platform, F(3.56, 85.47) = 30.15, p < .0005. Trial results did not interact significantly with genotype, F(3.56, 85.47) = 1.33, p = 0.24, suggesting both groups learned the location of the platform similarly. Between-subjects analyses indicated no effect of genotype, F(1, 24) = 0.03, p = 0.85. Further independent samples t-testing revealed no differences between WT and KO at any of the 8 different trials, p > 0.05.

For the probe trial (Dataset 2), as expected, male KO mice demonstrated similar time spent in the target quadrant, F(1,23) = 0.02, p = 0.88 (Figure 2B), compared to male wildtype (WT). Further independent samples t-testing revealed no differences in duration in any of the quadrants, p > 0.05.

fdb96939-aa16-44c5-b9e7-acaab153248e_figure2.gif

Figure 2. Performance in the Morris water maze in Fmr1 knockout males.

A. Fmr1 knockout males show no deficits in acquisition in performance. B. Performance during the probe trial is not impaired in the Fmr1 knockout males. C. When subjected to a reversal learning paradigm, Fmr1 knockout mice display increased latency to the new platform location, demonstrating deficits in cognitive flexibility. Knockout – KO, Wild type - WT.

Loss of Fmr1 impairs ability to update existing learning with new platform location

The week following the initial learning trials, animals were tested in the reversal learning paradigm (Dataset 3). During the 4 blocks of learning trials (Figure 2C), a one-way ANOVA with repeated measures revealed a significant within-subjects effect of trial, F(3, 69) = 3.8, p < 0.05. Trial results did not interact significantly with genotype, F(3, 69) = 1.28, p = 0.29. However, between-subjects analyses indicated a marginal effect of genotype, F(1, 23) = 3.93, p = 0.059 (Figure 2C). Further independent samples t-testing revealed that KO animals displayed significantly higher latency to reach the hidden platform during the third trial, t(23) = -2.96, p < 0.01. Together, these results demonstrate that Fmr1 KO males demonstrate decreased learning and altogether a lack of cognitive flexibility across all trials of the MWM reversal task.

Impairments were not due to deficits in vision or motor capabilities

Visible platform information was also assessed to ensure differences were not due to deficits in vision (Dataset 4). Results were analyzed using a repeated-measures ANOVA across the four visible platform trials on latency to the platform across the two blocks of trials. Results indicated no effect of block, F(1, 24) = 1.341, p = 0.26, nor an interaction of block and genotype, F(1, 24) = 0.0005, p = 0.98. There was not a significant effect of genotype on latency to the platform during these trials either, F(1, 24) = 0.98, p = 0.33 (Figure 3A). Altogether, these data suggest that differences in latency to the platform could not be attributed to deficits in visual perception in the Fmr1 KO male mouse. Moreover, differences in latency to the platform on the previous trials could not be attributed to impairments in swimming abilities, as no differences in swim speed were detected during the visible trials, t(11.17) = 1.526, p = 0.16 (Figure 3B).

fdb96939-aa16-44c5-b9e7-acaab153248e_figure3.gif

Figure 3. Performance in the Morris water maze visible trials.

A. Fmr1 knockout males showed no deficits in latency to the platform across the two blocks of the visible platform test. B. Fmr1 knockout males showed no deficits in swim speed across the visible platform test. Knockout – KO, Wild type - WT.

Raw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataAverage DurationAverage DurationAverage DurationAverage DurationAverage DurationAverage DurationAverage DurationAverage DurationAverage Velocity
Trial #DurationsubjectblockdirectionTotalMeanSubject GenotypeBlock 1Block 2Block 3Block 4Block 5Block 6Block 7Block 8All 8 Blocks
cmcm/s124KO48.2232227534.4344337519.0690687512.012011510.960960516.69169113.53853812.53753721.5976605
Trial 160.160161241E633.224994620.87762096124KO59.98498534.20920916.8418412521.871871259.8598592510.135134510.4604613.3883877522.77836917
Trial 260.160161241W602.509027319.35391002133KO46.3963962523.098097512.9879872514.6646647.8078078.258257511.711711259.8598592527.26860168
Trial 323.0230221241S207.348309717.26174456134KO26.0260257510.5355347527.8278272516.54154110.535534755.85585557.757757257.8578572525.88363122
Trial 449.5495491241N455.521209116.13707957134WT47.8228222516.66666622.2222217510.9109102511.61161118.768768258.7587582515.0150142527.44120934
Trial 4953.9539531242S622.388747520.31915438150WT25.57557517.992992259.4094098.908908257.95795758.3833837.3823826.38138123.59443469
Trial 5016.6166161242W203.075386421.13252475151KO45.29529512.2372367519.8448442515.5905902511.91191157.8578572512.3123117512.1121117528.63869212
Trial 5146.9469461242N498.488510718.24138763157KO40.1651647540.5405402512.937937259.634634523.49849825.4003997517.8928922522.5725722527.30209852
Trial 5220.220221242E185.107171115.80529845158WT27.2772767518.64364310.06005957.5075075.50550510.935935257.932932258.5335332527.85379228
Trial 16.1061061243E77.288617327.57548115160WT17.2672667516.7667662510.7107102513.2882877518.96896859.184183759.40940914.214213527.38955179
Trial 23.2032031243S34.7247250517.34501751161KO54.47947931.8568562531.88188142.29229210.9109102514.4394387514.164163517.192191525.07076942
Trial 328.6286281243N332.039648419.86272623167KO46.2212207555.5805802519.094093516.641641256.9569562520.64564511.8868862521.996996526.04063588
Trial 438.3383381243W389.276210917.8388498168KO33.38338316.81681658.4334327512.6376378.6586586.956956510.8358352513.863863529.18735602
Trial 497.8078071244W110.598354726.30661792177KO31.30630632.982982523.173172544.4944942517.59259224.974974257.88288259.4344337528.32697843
Trial 5012.2122121244N204.334416830.01913465178KO14.3143137522.672672522.4474467527.5775772520.3203217.267266517.642642521.37137129.13973879
Trial 517.1071071244E56.9600950715.80641403184WT36.7367362529.7297292515.7407426.451450756.031030517.0670667511.061060513.93893823.7113124
Trial 5220.920921244S214.502214919.84145424186WT39.314313758.0830822534.80980957.0570562511.861861259.15915853.50350318.218217528.39247078
Trial 122.7227221245E282.66928921.23207551188WT28.3783777513.7637632528.3533527511.68668630.030029523.2732727512.56256215.3153147524.73035054
Trial 27.4074071245N79.4333253720.34714192189WT22.047046530.20520511.6866862514.264263520.720720259.6846846.8318312517.64264230.16752414
Trial 34.4044041245S47.2695487617.48972692197KO34.859859518.7437432530.75575516.31631557.982982511.286285754.42942858.4084077527.09124933
Trial 49.3093091245W107.896332118.58422677198KO30.255254523.9739732513.6386382511.7117115.9809802512.16216157.10710656.2562557527.44491403
Trial 4936.2362361246N463.261847820.94110966203WT60.13513530.6556547512.837837521.5465469.7097092511.986986512.187186516.066065522.80465199
Trial 5013.5135131246W152.880838221.51098642204WT49.0990987518.3933927543.768768541.991991534.809809525.3253247515.2152147537.0620617524.39882581
Trial 515.0050041246E78.9297950234.28301251229KO25.800800517.967967516.4664657513.53853812.33733711.4114114.904904258.5335327526.68884999
Trial 5212.0120111246S125.697179519.31868176230KO32.382381512.087086521.921921259.834834256.7317317.4074079.5095094.65465428.28967034
Trial 13.0030021247S48.127465125.3049171231KO60.1101125.975975512.812812259.1591587510.1851847510.8358352512.212211756.50650628.27398499
Trial 24.1041041247W54.7743720922.79983284
Trial 320.420421247N229.814123220.68327478
Trial 426.6266261247E299.068221819.40059148
Trial 512.5025021248W49.4060466937.96668461
Trial 526.9069061248E93.2300569423.88124195
Trial 5320.320321248S234.914295621.33447983
Trial 5420.420421248N232.388885822.32273594
Trial 559.959961251E653.573531319.66626903
Trial 660.160161251W626.207351119.01462082
Trial 759.859861251S540.827444917.59890796
Trial 859.959961251N545.723613117.41782499
Trial 5338.1381381252S504.016357922.37832449
Trial 5413.3133131252W130.058604616.65749324
Trial 5559.959961252N687.284105221.19125478
Trial 5625.4254251252E328.886194421.06136675
Trial 547.3473471253E606.456492923.39188637
Trial 63.7037031253S34.7532231215.09498521
Trial 77.9079071253N93.2208340420.69502133
Trial 88.4084081253W100.428872522.29519799
Trial 5310.610611254W175.675041926.193937
Trial 5440.540541254N548.869480423.63449935
Trial 557.4074071254E119.145128123.33843568
Trial 5628.9289281254S352.019340422.54277933
Trial 52.6026021255E76.4714916147.74691898
Trial 64.8048041255N69.2659616124.71310666
Trial 724.5245241255S289.631562320.37618419
Trial 87.5075071255W73.7958967418.90309998
Trial 5312.0120111256N114.018582619.63871982
Trial 545.9059051256W54.9585406221.11676358
Trial 557.4074071256E89.3014041423.47687675
Trial 5615.2152151256S176.200501722.28155105
Trial 511.4114111257S192.457205127.46639573
Trial 613.5135131257W159.028698422.69568179
Trial 76.7067061257N54.0047312221.58030444
Trial 810.210211257E133.927437321.57959987
Trial 552.8028021258W25.1368772720.92647126
Trial 568.7087081258E156.540414328.95997814
Trial 573.0030021258S60.1365430333.37580768
Trial 5839.0390391258N453.733085221.89754915
Trial 960.160161331E696.750602823.51533156
Trial 1029.1291291331W349.695010421.83407943
Trial 1136.1361361331S415.163262720.43094249
Trial 1260.160161331N737.170137421.04094289
Trial 574.9049041332S51.1234854723.21470822
Trial 5814.0140141332W179.679960625.28173443
Trial 5955.0550541332N755.878389124.758115
Trial 6018.4184181332E232.584280824.20329687
Trial 917.2172171333E225.441366624.47998391
Trial 1011.9119111333S210.349745926.94095021
Trial 116.9069061333N100.168077626.33364954
Trial 1215.9159151333W236.115957224.31751277
Trial 9719.9199191334W289.806698127.57303944
Trial 986.7067061334n87.0423633820.22216653
Trial 9926.0260251334E310.581736926.29416026
Trial 1006.0060061334s56.1732681618.70570658
Trial 96.9069061335E108.198110431.79114285
Trial 106.0060051335N110.226933535.52152322
Trial 1113.6136131335S265.043753834.83929192
Trial 124.7047041335W70.9661792127.26740479
Trial 578.4084081336N194.371118535.95866048
Trial 584.0040031336W61.5147613832.34384635
Trial 5913.6136131336E230.412853530.6910015
Trial 607.0070061336S86.1510078726.08023511
Trial 911.2112111337S146.730015724.84462934
Trial 1014.3143141337W259.48724329.79629274
Trial 1112.9129121337N205.204054827.33318799
Trial 128.4084081337E168.973946638.36477746
Trial 5915.5155151338W258.536269229.34973382
Trial 606.4064061338E135.099994538.5614087
Trial 614.6046041338S53.1356616423.07936397
Trial 6212.9129121338N188.047838827.62643344
Trial 134.1041041341E149.913207365.11453821
Trial 1460.160161341W664.920844120.00770772
Trial 1512.3123121341S176.336086626.29250385
Trial 1627.5275271341N276.507789318.05432553
Trial 6121.8218211342S301.346793325.08711985
Trial 625.9059051342W55.7352684921.4152265
Trial 636.4064061342N85.3351352623.68049907
Trial 648.0080071342E79.7829658518.53561882
Trial 1325.8258251343E364.073118525.6133212
Trial 1460.160161343S675.884869721.16642571
Trial 1518.3183181343N197.664003420.14963355
Trial 167.0070061343W76.3142884816.94178015
Trial 6117.2172171344W249.426013923.95928518
Trial 6224.8248241344N313.739133824.87502247
Trial 6315.5155151344E155.549996620.44663566
Trial 648.6086081344S121.246552526.33158077
Trial 1311.8118111345E228.091282729.59262779
Trial 1414.5145141345N184.770960223.66491125
Trial 1510.0100091345S164.269693928.79042753
Trial 165.8058051345W75.5415764620.39622496
Trial 617.2072071346N144.188707829.39685442
Trial 624.3043041346W76.1299033526.22544899
Trial 632.5025021346E52.4601704434.93849012
Trial 649.4094091346S133.127300825.57581186
Trial 137.5075071347S113.871592925.85402504
Trial 146.5065061347W86.807266927.10012837
Trial 157.1071071347N87.2477452324.21125533
Trial 169.9099091347E183.928044131.68003089
Trial 636.0060051348W53.1250805116.08242037
Trial 6412.4124121348E275.796149229.31068998
Trial 655.5055051348S137.361078430.49417946
Trial 667.5075071348N120.202483427.29144837
Trial 1760.060061501E813.418152422.14181685
Trial 1854.5545541501W499.791055617.04065682
Trial 1948.7487481501S508.365016519.83815099
Trial 2027.9279271501N325.37625619.58137283
Trial 6543.7437431502S653.506423925.70287979
Trial 6610.710711502W95.0720357817.26853383
Trial 676.5065061502N108.474210229.28805742
Trial 685.7057051502E87.9584389627.45952961
Trial 1722.2222221503E305.163888628.49147273
Trial 181.5015011503S22.7052146325.20278232
Trial 1929.2292291503N401.950559624.04482402
Trial 2035.9359351503W472.814316422.81844287
Trial 655.8058051504W86.75067730.95141429
Trial 6610.910911504N173.417022929.36331407
Trial 6713.5135131504E246.962540444.85740021
Trial 6813.4134131504S248.719387734.03708531
Trial 1715.6156151505E234.488495428.22337142
Trial 189.5095091505N161.412540431.61788443
Trial 194.5045041505S46.8234709421.26211488
Trial 2016.8168161505W197.979005522.47510962
Trial 6521.3213211506N324.250683924.53988693
Trial 6614.0140131506W195.421221223.80802427
Trial 6714.6146141506E205.103114226.96025533
Trial 6825.1251251506S323.29942522.27420833
Trial 1714.6146141507S178.634408824.11566143
Trial 186.0060061507W77.1088383826.56267366
Trial 195.6056051507N88.9084671429.60651878
Trial 208.8088081507E119.210282128.35503221
Trial 6718.8188181508W260.555241825.02832742
Trial 682.6026021508E96.8190737974.40179603
Trial 6914.6146141508S286.78862727.02847546
Trial 7024.0240231508N323.617621623.77162485
Trial 2115.0150141511E255.231939634.45632769
Trial 2260.160161511W675.836580120.27509234
Trial 236.5065061511S68.2693790122.00037395
Trial 2420.620621511N213.941846221.80896641
Trial 6929.8298291512S326.214320821.72587975
Trial 7017.6176171512W219.820018721.96002018
Trial 7115.6156151512N182.011284821.9071352
Trial 728.9089081512E127.441401427.67695003
Trial 2116.8168161513E218.549102122.2786267
Trial 2211.5115111513S180.871148227.37731961
Trial 236.4064061513N105.528270428.49264235
Trial 242.9029031513W38.9752565624.33516934
Trial 695.9059051514W75.2822351826.8596298
Trial 7010.310311514N166.405026533.24761166
Trial 7111.4114111514E110.779585818.14243849
Trial 728.0080071514S75.0154961319.72117185
Trial 212.2022021515E26.4183604921.99329109
Trial 2215.6156151515N202.106605622.68589948
Trial 234.4044041515S54.2667571218.69395997
Trial 249.6096091515W100.891987419.01718609
Trial 6915.9159151516N263.911096927.75234064
Trial 706.1061061516W61.9435938320.62721441
Trial 718.4084081516E130.738561629.68359248
Trial 723.1031031516S26.31743913.83741753
Trial 212.5025021517S25.0806655317.89685844
Trial 223.1031031517W38.4938412927.46812736
Trial 2318.2182181517N245.238445925.25703028
Trial 245.7057051517E76.4457640624.63526743
Trial 714.1041041518W68.1349212121.27086999
Trial 727.9079071518E122.634673425.52333853
Trial 735.2052051518S52.4326745816.36881685
Trial 748.3083081518N129.324275930.04534426
Trial 131.8318311571E475.833492827.16329967
Trial 260.060061571W673.802665420.52222175
Trial 360.160161571S665.243547219.26313852
Trial 429.1291291571N285.106593717.36715769
Trial 556.4064061572S83.4302948724.51378232
This is a portion of the data; to view all the data, please download the file.
Dataset 1.Learning Trial Data.
This datasheet contains the raw data exported from the Ethovision program (Columns A – G) as well as the transformed dataset that was used for analysis for the learning trials (Columns J – T)
Raw DataDistance movedIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneIn zoneVelocityOrganized Data
ArenaArenaInnerInnerOuterOuterOQuadOQuadLQuad2LQuad2OZoneOZoneRZoneRZoneTzoneTzoneLZoneLZoneTQuad1TQuad1RQuadRQuadDuration in QuadDuration in QuadDuration in QuadDuration in Quad
subjectblockdirectionTotalDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyDurationFrequencyMeanSubjectGenotypeOppositeLeftTargetRight
cmssssssssssscm/s150WT13.61361315.11511616.81681714.614614
Trial 1124probeN827.250915460.16016146.146147814.01401398.30830848.20820832.10210231.80180141.20120230.600601125.625625818.018019724.45039738151WT5.8058056.20620529.3293318.71872
Trial 2125probeN852.532826860.16016144.6446451015.515515108.60860955.70570530.200212.10210353.20320460.4004126.626627819.219219923.72368797160WT9.6096117.21721724.2242258.908908
Trial 3133probeN N1009.72444460.16016149.44945510.7107158.108108724.924924111.20120130.70070221.60160232.502501522.422422104.704706529.23811234161WT3.4034034.70470430.93093120.920922
Trial 4134probeN814.21381960.16016154.25425685.90590485.205206421.62162111-00.500513.40340494.804805831.03103192.302302124.72338691184WT5.30530513.51351334.5345366.706706
Trial 5150probeN796.78279160.16016157.65765942.502501413.6136131215.11511680.300310.100110.200211.601603316.816817814.6146141224.41674164186WT11.71171220.62061919.8198217.907908
Trial 6151probeN754.879159560.06006156.45645633.60360435.80580576.2062056-01.801861.9019024-029.329331118.718721122.24556175188WT15.6156156.60660823.52352314.414414
Trial 1157probeN925.280468560.16016144.5445451015.615615109.60961619.6196199-00.100112.20220351.901901425.82582585.105106526.9491395189WT8.30830919.61961723.8238268.408408
Trial 2158probeN908.602690260.06006144.644645915.415415107.50750846.7067074-01.50150132.70270460.7007221.021022824.824823824.93664948203WT6.30630510.41041124.72472418.71872
Trial 3160probeN959.430160259.95996153.75375266.20620869.60961617.21721790.60060120.60060113.00300391.401402424.224225108.908908728.78290244204WT17.71771712.91291212.31231317.217218
Trial 4161probeN842.844502159.95996151.551551118.408409113.40340334.7047043-03.20320343.60360380.3003130.9309311020.920922924.98521767124KO8.3083088.20820825.62562518.018019
Trial 5167probeN771.591514660.16016136.0360381324.1241221311.811811624.62462471.80180240.50050111.30130240.4004115.71571768.008008424.47047003125KO8.6086095.70570526.62662719.219219
Trial 6168probeN984.934837960.16016147.147148813.013012912.612613812.61261171.701750.300310.80080130.800801317.917918717.017018928.11285682133KO8.10810824.92492422.4224224.704706
Trial 7184probeN832.100725860.06006149.849849910.21021195.305305313.51351380.800811.00100113.403401101.2012334.534536106.706706424.23524297134KO5.20520621.62162131.0310312.302302
Trial 8186probeN935.367195960.06006153.55355556.506505511.711712920.620619101.30130230.400411.30130241.801803519.81982187.907908627.24290702157KO9.6096119.61961925.8258255.105106
Trial 9188probeN810.596697860.16016150.35035199.809809915.61561576.60660870.800821.30130142.40240260.100101123.523523814.414414823.81723042158KO7.5075086.70670721.02102224.824823
Trial 10189probeN985.254025960.16016150.6506589.5095188.308309619.61961791.10110130.800831.40140240.8008223.823826118.408408727.96218871167KO11.81181124.62462415.7157178.008008
Trial 11176probeN811.481780760.16016149.249251610.91090967.607608514.81481681.4014012-04.80480480.7007235.135134102.602602523.29512099168KO12.61261312.61261117.91791817.017018
Trial 12177probeN817.297063360.16016153.95395456.206206511.611614821.0210290.400410.60060114.50450572.002001520.72072176.806805624.59276168176KO7.60760814.81481635.1351342.602602
Trial 13178probeN908.027411260.06006143.6436441016.4164161013.213213623.92392390.700720.40040110.90090222.602603615.41541677.507508427.40542208177KO11.61161421.0210220.7207216.806805
Trial 1197probeN890.050511560.16016149.149151011.0110199.709709418.31831991.20120330.700724.60460472.1021526.62662795.505505525.2602424178KO13.21321323.92392315.4154167.507508
Trial 2198probeN834.139535560.06006157.05705843.003002410.810811811.71171191.70170340.400422.70270350.900902225.0250241112.512514925.09957071197KO9.70970918.31831926.6266275.505505
Trial 3203probeN772.213901260.16016149.949949710.21021176.306305610.41041150.70070121.60160123.80380560.2002124.724724918.71872922.29600535198KO10.81081111.71171125.02502412.512514
Trial 4204probeN936.351373360.16016121.42142938.738741017.717717712.91291250.4004011-00.90090220.500501112.312313517.217218727.92283915229KO5.30530426.12612722.2222236.306306
Trial 5229probeN953.300684359.95996141.7417441218.218216125.305304426.12612780.400410.800821.50150142.302303522.22222396.306306526.82668573231KO12.01201219.5195223.1231235.505505
Trial 6230probeN70.8433459812.9129121-012.912912111.511513-0-0-0-0-0-01.401402258.97714337
Dataset 2.Probe Trial Data.
This datasheet contains the raw data exported from the Ethovision program (Columns A - AB) as well as the transformed dataset that was used for analysis for the probe trial (Columns AC – AI)
Raw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataAverage DurationAverage DurationAverage DurationAverage Duration
In zoneDistance movedVelocitySubjectGenotypeBlock 1Block 2Block 3Block 4
Arena150WT12.51251220.145144755.5055059.759759
DurationsubjectblockdirectionTotalMean151WT13.938938510.6106111.66166119.0190185
scmcm/s160WT32.6576572545.9959957521.7217212522.0470465
Trial 136.736736124R1N440.219957520.36017206161WT25.4003997511.486485754.4544537510.28528475
Trial 26.506506124R1E143.180472334.0565138184WT29.6796797.3323326.156155516.0910905
Trial 316.116116124R1S187.026161321.98107791186WT19.3443447.98298258.28328257.0070065
Trial 422.122122124R1W234.930626718.62664016188WT12.96296255.830830255.6056055.95595525
Trial 5035.735735124R2W517.030052826.35270243189WT5.7307302515.165164757.13213153.95395325
Trial 515.105105124R2N79.8705558823.46784708203WT19.844844258.5835836.60660615.54054
Trial 525.305305124R2S86.0202547829.63251709204WT17.1421412526.55155113.763763512.98798725
Trial 5317.517517124R2E230.468529724.75678443124KO20.3703715.91591559.70970927.52752675
Trial 122.822822124R3E296.788159622.46147785125KO20.845845514.1891887531.8818812530.83083
Trial 22.402402124R3W37.2654814128.63711434133KO12.987987518.218217521.34634614.0140135
Trial 49.709709124R3S170.759456336.29547337134KO39.1891887521.8218212524.29929928.35335275
Trial 53.903903124R3N45.2341670726.58172779158KO33.433432758.033032513.7387382512.28728675
Trial 507.307307124R4S116.689860330.67716617167KO14.53953913.2632627516.2912907510.485485
Trial 5115.015014124R4W210.436848624.73250975168KO5.8058052521.49649638.5885882520.395395
Trial 5240.84084124R4N496.199481721.36653384176KO11.76176110.7107097518.643642758.433433
Trial 5446.946946124R4E566.760165221.69322917177KO23.19819824.54954923.42342315.565565
Trial 531.1311311251N406.926053922.8381432178KO15.7157152524.34934915.940940514.63963925
Trial 627.6276271251E302.45800421.58252796197KO27.027026528.62862825.6006002525.85085
Trial 721.6216211251S S256.260325420.15779826198KO43.8438432532.807807523.273272515.29028975
Trial 83.0030031251W38.1366011721.16579382229KO18.168167528.3033035.4054047511.636636
Trial 5430.630631252W428.458696924.04664489230KO9.884884259.20920855.83083058.00800775
Trial 5515.3153151252N186.647619621.6814981231KO25.0750747514.489489259.15915912.66266225
Trial 564.5045041252S60.7636386320.93202377
Trial 576.3063061252E78.8664245621.29393263
Trial 654.4544541253E739.50378624.79074669
Trial 718.8188181253W228.990515223.34301694
Trial 87.5075071253S90.069617421.94622933
Trial 946.7467461253N569.826491620.40346771
Trial 5557.9579571254S799.384870425.19197489
Trial 566.8068061254W91.7105152824.11021133
Trial 5722.0220211254N342.247544428.02502155
Trial 5836.5365361254E442.56175422.78964646
Trial 917.8178171331N285.845358729.13871838
Trial 104.6046041331E54.8157738626.07662824
Trial 1126.1261261331S367.846184624.33631692
Trial 123.4034031331W31.9259836216.78636291
Trial 585.9059051332W99.427900633.10947952
Trial 5913.7137131332N223.606026429.78431697
Trial 6028.5285281332S418.374828825.02731972
Trial 6124.7247241332E350.739609224.33256632
Trial 1044.3443441333E678.0439527.76090386
Trial 1112.6126121333W199.953590128.94981702
Trial 1220.120121333S239.375858725.44002649
Trial 138.3083081333N99.1574280624.76457265
Trial 5926.8268261334S468.862926630.81540148
Trial 6016.0160161334W241.362564526.4968228
Trial 613.4034031334N76.5520029742.4863584
Trial 629.8098091334E152.793795227.25732122
Trial 1327.6276271341N389.089738923.41571051
Trial 1454.3543541341E689.564633723.9192792
Trial 1559.3593591341S709.11543121.53211198
Trial 1615.4154151341W209.428147221.79362228
Trial 627.5075071342W141.027781429.97591411
Trial 633.7037031342N49.2177947320.48690553
Trial 6428.2282281342S401.49412724.1622052
Trial 6547.8478471342E646.865155124.38560026
Trial 1420.220221343E334.259136632.4198885
Trial 1525.2252251343W365.321362524.82694178
Trial 1635.3353351343S432.291163422.97122115
Trial 1716.4164161343N252.958388327.17263547
Trial 6338.8388381344S618.545219828.34525491
Trial 6454.8548541344W670.818894522.19033568
Trial 653.1031031344N49.1923698624.57158957
Trial 6616.6166161344E196.013522823.59246432
Trial 1730.930931501N459.526557224.94929567
Trial 184.1041041501E82.3437141735.76582439
Trial 195.5055051501S67.3110401721.01366078
Trial 209.5095091501W116.795767620.83553356
Trial 664.5045041502W35.9136124117.08460936
Trial 6756.3563561502N801.727382224.9509544
Trial 685.4054051502S63.0383124522.49117064
Trial 6914.3143141502E201.756252623.99458798
Trial 184.4044041503E63.3239253827.50459207
Trial 193.3033031503W42.809343121.38326927
Trial 2011.5115111503S140.199355123.73882809
Trial 212.8028021503N57.86998736.13260927
Trial 6713.7137131504S217.095564131.89390041
Trial 686.0060051504W75.5391194623.5823606
Trial 6914.8148141504N205.02036125.28583122
Trial 704.5045041504E68.28498628.42364244
Trial 2112.3123121511N209.324015929.45277697
Trial 2215.7157151511E226.18706725.10676123
Trial 2315.5155151511S154.794301619.57461337
Trial 2412.2122121511W115.144990417.97340562
Trial 7019.1191191512W289.786731129.24213502
Trial 713.7037031512N37.4415889615.58507426
Trial 728.9089081512S111.578412822.29336191
Trial 7310.710711512E136.014857624.70525394
Trial 228.1081081513E79.9686024217.75302122
Trial 2318.8188181513W262.436548624.27537754
Trial 249.8098091513S161.534908726.45467235
Trial 259.9099091513N135.432341828.78658994
Trial 7136.0360351514S455.914867223.35687036
Trial 7225.4254251514W328.134822624.10343984
Trial 733.5035031514N26.641232414.785874
Trial 7411.1111111514E152.054873325.31713827
Trial 544.844844158R1N643.351824924.16198201
Trial 61.701701158R1E13.5376461715.02679135
Trial 759.059058158R1S759.744769623.35338124
Trial 828.128128158R1W345.677456722.13664733
Trial 5716.316316158R2W227.234608425.22305477
Trial 583.403403158R2N80.7660369440.34265095
Trial 597.907907158R2S124.938476826.55608774
Trial 604.504504158R2E97.7967689344.40865416
Trial 526.126126158R3E487.000712631.59180014
Trial 67.907907158R3W113.080597826.89700869
Trial 717.417417158R3S254.747200324.95024285
Trial 83.503503158R3N122.653685664.49006245
Trial 572.902903158R4S48.2572834426.78280156
Trial 587.807807158R4W116.361150327.67733293
Trial 593.903903158R4N71.1033032135.51611742
Trial 6034.534534158R4E556.919483726.62021492
Trial 94.904904160R1N77.1183214333.49619321
Trial 1060.16016160R1E977.931645128.0733845
Trial 115.505505160R1S77.539939924.98786413
Trial 1260.06006160R1W700.880096220.35404812
Trial 6160.16016160R2W981.709326127.86157206
Trial 623.503503160R2N62.9369199529.94001728
Trial 6360.16016160R2S814.011962724.2745714
Trial 6460.16016160R2E803.494956523.06584392
Trial 941.741741160R3E735.539917330.11494721
Trial 108.808808160R3W136.528587226.22923277
Trial 1125.325325160R3S362.993941126.86154588
Trial 1211.011011160R3N210.397727530.90989851
Trial 6123.323323160R4S396.91383330.50129649
Trial 6230.93093160R4W462.570120826.10778084
Trial 635.605605160R4N30.6339584110.20111049
Trial 6428.328328160R4E535.271441527.14397113
Trial 133.503503161R1N51.0524359526.84286027
Trial 145.905905161R1E95.4507240429.7985432
Trial 1546.046045161R1S678.99006524.75587148
Trial 1646.146146161R1W619.692543322.26881412
Trial 653.803803161R2W61.3140179126.63162196
Trial 6613.613613161R2N242.393863229.89524426
Trial 6724.624624161R2S430.953170628.32382122
Trial 683.903903161R2E83.1233317341.52013253
Trial 133.803803161R3E78.0323610743.3079823
Trial 146.406406161R3W103.418342926.49100645
Trial 155.605605161R3S83.5545530425.294233
Trial 162.002001161R3N0.8560367550.777437441
Trial 653.603603161R4S51.4219276728.53917342
Trial 666.706706161R4W102.768648329.3331298
Trial 672.402402161R4N32.1493792329.19749984
Trial 6828.428428161R4E466.764528128.43278368
Trial 1712.612612167R1N192.42251127.85942314
Trial 189.609609167R1E216.517007940.05564679
Trial 196.506506167R1S3.7353002750.867805532
Trial 2029.429429167R1W464.514824425.4972768
Trial 6910.91091167R2W152.88198324.24271317
Trial 7013.313313167R2N307.466693736.13639883
Trial 719.509509167R2S120.397510322.69377652
Trial 7219.319319167R2E387.622784832.81654316
Trial 1740.040039167R3E684.93103229.24127899
Trial 186.706706167R3W101.415565625.97800363
Trial 195.305305167R3S107.905620529.13451772
Trial 2013.113113167R3N191.130630126.89287144
Trial 693.003003167R4S154.994365367.32150742
Trial 7021.421421167R4W296.497413326.92736573
Trial 711.601601167R4N14.5825596618.20998959
Trial 7215.915915167R4E257.933949827.70710273
Trial 212.202202168R1N31.9173682819.92842475
Trial 224.704704168R1E117.179692953.21026205
Trial 236.406406168R1S96.1681563925.96539838
Trial 249.909909168R1W168.938274226.78877501
Trial 7315.115115168R2W259.253717730.11561837
Trial 7422.822822168R2N427.915786529.68666722
Trial 7531.731731168R2S510.523302926.28931663
Trial 7616.316316168R2E254.368806325.66812981
Trial 2160.16016168R3E1086.83742629.58449175
Trial 2260.16016168R3W879.005932824.12436742
Trial 2323.723723168R3S385.380803627.30464516
Trial 2410.31031168R3N181.370187628.31074707
Trial 7342.542542168R4S789.102503229.08906491
Trial 745.305305168R4W80.0378495724.98683126
Trial 7528.528528168R4N490.686541829.0056682
Trial 765.205205168R4E70.7317199226.17075206
Trial 4128.928928176R1N499.652205629.36190911
Trial 424.004003176R1E62.0112257622.94415963
Trial 4311.111111176R1S211.938017432.57326376
Trial 443.003002176R1W36.977032419.44213996
Trial 9315.015014176R2W189.034323224.21092882
Trial 9414.014013176R2N227.208809628.7318466
Trial 958.808808176R2S185.926764332.58611275
Trial 965.005004176R2E141.66203645.65175091
Trial 4117.017016176R3E297.919479431.32858421
Trial 4213.613613176R3W121.378199817.07841575
Trial 438.008007176R3S99.0665181419.03220507
Trial 4435.935935176R3N515.63324224.76527618
Trial 935.605605176R4S88.1631464728.41129322
Trial 947.907907176R4W113.259326524.59696226
Trial 9512.012012176R4N162.599507424.24431837
Trial 968.208208176R4E203.952404439.9506938
Trial 4560.06006177R1N933.509519226.19596511
Trial 467.207207177R1E182.754408141.49357316
Trial 4714.114114177R1S174.922696223.61457103
This is a portion of the data; to view all the data, please download the file.
Dataset 3.Reversal Trial Data.
This datasheet contains the raw data exported from the Ethovision program (Columns A – G) as well as the transformed dataset that was used for analysis for the reversal trials (Columns J – O)
Raw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataRaw Export DataAverage DurationAverage DurationAverage DurationAverage DurationAverage DurationAverage Duration
TrialsubjectGenotypeblockdirectionTotalDurationMeanSubjectGenotypeAverage Velocity Of 4 Visible TrialsTrial 1Trial 2Trial 3Trial 4Block 1Block 2
cmscm/s150WT30.188012966.1061065.4054052.3023024.7047045.75575553.503503
ArenaVelocity151WT35.816442568.5085086.8068065.0050044.1041047.6576574.554554
Trial 291242V1W57.835148734.00400323.11091988160WT33.2591518.0186.3063111.11113.903912.1621557.5075
Trial 301242V1S489.109076629.62962923.95196149161WT25.80892510.014.60465.30532.50257.30733.9039
Trial 531242V2N75.16121094.30430431.28586242184WT27.62487519.71976.1061125.82585.00512.91290515.4154
Trial 541242V2E722.94857952.05205123.44888019186WT38.7558519.81983.10316.106113.303311.461454.704705
Trial 311252V1W58.434479722.90290229.18803542188WT39.08882.00214.114118.518519.11918.0580518.8188
Trial 321252V1S94.142015993.90390340.89039663189WT29.18897514.31439.6096160.060125.125111.96195542.5926
Trial 551252V2N517.734471639.43943924.05658809203WT22.43652523.62366.3063129.929913.01314.96495521.47145
Trial 561252V2E246.731527612.81281233.30875925204WT25.30472530.33037.5075115.615615.01518.91890515.3153
Trial 331332V1W95.984872955.70570529.96526527124KO25.4494064.00400329.6296294.30430452.05205116.81681628.1781775
Trial 341332V1S62.304350293.60360328.29182299125KO31.860944852.9029023.90390339.43943912.8128123.403402526.1261255
Trial 571332V2N25.186687153.10310319.35501971133KO25.876805245.7057053.6036033.1031035.0050044.6546544.0540535
Trial 581332V2E77.763057375.00500425.89511299134KO27.724826858.0080075.30530513.51351311.6116116.65665612.562562
Trial 351342V1W98.015427958.00800721.75941938157KO33.7864253.603615.315345.845810.019.4594527.9279
Trial 361342V1S76.770819965.30530523.24062059158KO26.69562513.713727.12715.205257.057120.420431.13115
Trial 591342V2N232.32430713.51351330.94561738167KO23.27407560.06012.502560.16027.8078131.281333.984005
Trial 601342V2E227.42606911.61161134.95365007168KO26.85232560.160260.060146.746732.432460.1101539.58955
Trial 371501V1W86.24057376.10610623.28494458176KO30.20542510.81086.006014.0046.406418.4084055.205205
Trial 381501V1S64.419185275.40540522.98385286177KO27.2570755.0054.80485.105114.60464.90494.854855
Trial 611501V2N65.866749082.30230236.55605428178KO28.53322521.621640.340324.824812.412430.9809518.6186
Trial 621501V2E102.5059164.70470437.92720012197KO26.4920256.106113.403421.92197.707714.75475514.814805
Trial 391511V1W94.842168848.50850820.59724519198KO26.42846.506516.1061120.62063.30336.3063111.96195
Trial 401511V1S75.003559116.80680620.81350508229KO28.6477754.40446.7067112.71273.50355.5555558.1081
Trial 631511V2N128.83005485.00500445.96474419230KO28.202544.54453.603619.21929.0090124.0740514.114105
Trial 641511V2E89.513866214.10410455.89027578231KO27.42017512.91294.90495.405417.507518.90896.45646
Trial 11572V1W121.0533.603657.5867
Trial 21572V1S319.70515.315333.2693
Trial 271572V2N670.99145.845824.6441
Trial 281572V2E121.92510.0119.6456
Trial 31582V1W218.15113.713727.2416
Trial 41582V1S425.52327.127127.0762
Trial 291582V2N61.74975.205226.8208
Trial 301582V2E821.42857.057125.6439
Trial 51601V1W316.78418.01831.6467
Trial 61601V1S110.9276.3063134.6301
Trial 311601V2N200.0211.111131.7175
Trial 321601V2E91.20113.903935.0423
Trial 71611V1W128.28510.0127.2673
Trial 81611V1S73.47254.604624.4664
Trial 331611V2N78.19985.305322.9769
Trial 341611V2E39.97522.502528.5251
Trial 91672V1W921.17860.060125.2818
Trial 101672V1S15.34192.502511.7897
Trial 351672V2N954.81960.160226.4962
Trial 361672V2E115.2777.8078129.5286
Trial 111682V1W854.17860.160225.6253
Trial 121682V1S838.13360.060123.9227
Trial 371682V2N763.72446.746727.3462
Trial 381682V2E543.71232.432430.5151
Trial 211762V1W227.34610.810837.2325
Trial 221762V1S75.44426.0060125.9892
Trial 471762V2N61.41594.00429.2164
Trial 481762V2E105.1256.4064128.3836
Trial 231772V1W79.10845.00529.2701
Trial 241772V1S82.13474.804831.5587
Trial 491772V2N54.73335.1051119.5281
Trial 501772V2E60.27024.604628.6714
Trial 251782V1W363.85421.621630.5454
Trial 261782V1S624.25140.340327.2326
Trial 511782V2N437.76424.824828.962
Trial 521782V2E191.94212.412427.3929
Trial 131841V1W360.69219.719732.1724
Trial 141841V1S102.2276.1061129.1784
Trial 391841V2N312.16325.825822.1171
Trial 401841V2E64.94085.00527.0316
Trial 151861V1W373.83919.819831.3837
Trial 161861V1S85.9123.103150.486
Trial 411861V2N48.17456.1061116.0421
Trial 421861V2E108.6213.303357.1116
Trial 171881V1W80.83372.00280.753
Trial 181881V1S160.49814.114122.9053
Trial 431881V2N303.118.518525.4451
Trial 441881V2E335.53319.119127.2518
Trial 191891V1W215.80214.314328.3666
Trial 201891V1S218.6779.6096138.3259
Trial 451891V2N859.43360.060125.783
Trial 461891V2E381.58425.125124.2804
Trial 531972V1W86.43566.1061126.9841
Trial 541972V1S40.25163.403420.1057
Trial 671972V2N369.00721.921929.9706
Trial 681972V2E124.4277.7077128.9077
Trial 551982V1W82.50336.5065124.976
Trial 561982V1S84.28536.1061124.0574
Trial 691982V2N273.07320.620625.2593
Trial 701982V2E59.75943.303331.4209
Trial 572031V1W339.37723.623623.8759
Trial 582031V1S85.09096.3063122.37
Trial 712031V2N385.32129.929923.4717
Trial 722031V2E156.37813.01320.0285
Trial 592041V1W442.78630.330324.9911
Trial 602041V1S91.15557.5075124.612
Trial 732041V2N239.82715.615625.762
Trial 742041V2E204.44915.01525.8538
Trial 612292V1W70.31734.404428.0988
Trial 622292V1S113.9756.7067129.9635
Trial 752292V2N209.6312.712731.2568
Trial 762292V2E40.47573.503525.272
Trial 632302V1W727.02244.544527.7212
Trial 642302V1S55.32123.603627.633
Trial 772302V2N335.42919.219229.6543
Trial 782302V2E139.1479.0090127.8015
Trial 652312V1W217.0212.912928.1562
Trial 662312V1S63.02644.904926.2348
Trial 792312V2N62.00965.4054125.8115
Dataset 4.Visible Platform Data.
This datasheet contains the raw data exported from the Ethovision program (Columns A – H) as well as the transformed dataset that was used for analysis of the visible platform trials (Columns K – S)

Discussion

As expected, deletion of Fmr1 did not impact initial spatial learning in the MWM. The current study did, however, demonstrate impairments in cognitive flexibility in the Fmr1 KO. As previously mentioned, other studies have not before detected such changes, and this discrepancy could be attributed to methodological differences10. In the aforementioned study, training occurred over 8 days, with only 3 training trials per day, and the reversal paradigm consisted of 4 days, with 3 trials per day. Furthermore, in support of our findings, deficits in long-term potentiation in the prefrontal cortex have been demonstrated in the Fmr1 KO mouse, the area on which the ability to adapt to a new location in this task is dependent on 1113. Moreover, this ability to adapt to a new location is mediated through multi-synaptic connections between the hippocampus and the prefrontal cortex13. This proposed mechanism further supports our findings of no change to the initial spatial learning phase, as lesions to this area did not impact initial learning performance in spatial navigation11.

The current study provides preliminary evidence that could be applied to tease apart subtle differences between the male and female Fmr1 KO phenotype, which has been difficult to conclusively evaluate. Future studies should expand upon these findings in females, as many studies have demonstrated a sex-specific effect of loss of Fmr1 on behavior (discussed in a recent review14)24,15. Overall, this study corroborates and extends previous evidence of impaired cognitive flexibility in the male Fmr1 KO mouse.

Data availability

Dataset 1– “Learning Trial Data – CSV.csv”

This datasheet contains the raw data exported from the Ethovision program (Columns A – G) as well as the transformed dataset that was used for analysis for the learning trials (Columns J – T). http://dx.doi.org/10.5256/f1000research.14969.d20606816

Dataset 2 – “Probe Trial Data – CSV.csv”

This datasheet contains the raw data exported from the Ethovision program (Columns A - AB) as well as the transformed dataset that was used for analysis for the probe trial (Columns AC – AI). http://dx.doi.org/10.5256/f1000research.14969.d20606917

Dataset 3 – “Reversal Trial Data – CSV.csv”

This datasheet contains the raw data exported from the Ethovision program (Columns A – G) as well as the transformed dataset that was used for analysis for the reversal trials (Columns J – O). http://dx.doi.org/10.5256/f1000research.14969.d20607618

Dataset 4 – “Visible Platform Data – CSV.csv”

This datasheet contains the raw data exported from the Ethovision program (Columns A – H) as well as the transformed dataset that was used for analysis of the visible platform trials (Columns K – S). http://dx.doi.org/10.5256/f1000research.14969.d20607719

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 07 Jun 2018
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Nolan SO and Lugo JN. Reversal learning paradigm reveals deficits in cognitive flexibility in the Fmr1 knockout male mouse [version 1; peer review: 1 approved, 2 approved with reservations] F1000Research 2018, 7:711 (https://doi.org/10.12688/f1000research.14969.1)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 07 Jun 2018
Views
10
Cite
Reviewer Report 16 Jul 2018
Lisa Monteggia, Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, USA 
Approved
VIEWS 10
The current study examines male Fmr1 knockout mice in the Morris Water maze.  This group focuses on the FVB strain  as previous work has shown background strain differences can impact the phenotype of Fmr1 knockouts.  The authors show that the ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Monteggia L. Reviewer Report For: Reversal learning paradigm reveals deficits in cognitive flexibility in the Fmr1 knockout male mouse [version 1; peer review: 1 approved, 2 approved with reservations]. F1000Research 2018, 7:711 (https://doi.org/10.5256/f1000research.16297.r34793)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
13
Cite
Reviewer Report 02 Jul 2018
Andre Fenton, Center for Neural Science, New York University, New York, NY, USA 
Approved with Reservations
VIEWS 13
I am afraid that I did not find this manuscript and the results to be compelling.
The experimental design is straightforward but the analysis is questionable and the report is not as scholarly as it should be.

... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Fenton A. Reviewer Report For: Reversal learning paradigm reveals deficits in cognitive flexibility in the Fmr1 knockout male mouse [version 1; peer review: 1 approved, 2 approved with reservations]. F1000Research 2018, 7:711 (https://doi.org/10.5256/f1000research.16297.r34795)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
14
Cite
Reviewer Report 20 Jun 2018
Laura Smith, Department of Neuroscience & Experimental Therapeutics, Texas A&M Health Science Center, Bryan, TX, USA 
Approved with Reservations
VIEWS 14
The study authored by Nolan and Lugo investigates the ability of Fmr1 KO mice on the FVB.129 background to demonstrate proper reversal learning in the Morris water maze (MWM). Background strain appears to make a large difference in observed cognitive ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Smith L. Reviewer Report For: Reversal learning paradigm reveals deficits in cognitive flexibility in the Fmr1 knockout male mouse [version 1; peer review: 1 approved, 2 approved with reservations]. F1000Research 2018, 7:711 (https://doi.org/10.5256/f1000research.16297.r34794)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 07 Jun 2018
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.